Overview

Cheno Effect on Transit in Health and IBS-C

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that the naturally occurring bile acid, chenodeoxycholic acid, induces acceleration of colonic transit in health and in patients with constipation-predominant Irritable Bowel Syndrome (IBS-C).
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
National Center for Research Resources (NCRR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Chenodeoxycholic Acid